Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Non-Hodgkin's Lymphoma treatment details. Chemotherapy. The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States



Survival: 6.9 months
   
Toxicity Grade: 4
   
Treatments: Chemotherapy
   
Drugs:
Country: United States
   
City/State/Province: Houston, Texas
   
Hospital: The University of Texas M. D. Anderson Cancer Center
   
Journal: Link
   
Date: 8/2009

Description:
Patients:
This phase II study involved 119 non-Hodgkin’s lymphoma patients with a median age of 60 years; 54% were male.

Treatment:
Patients were treated a drug called Marqibo, which is a formulation of the chemotherapy agent vincristine.

Toxicities:
The most severe toxicities were of grade 4 and included shortness of breath, neurotoxicity, neutropenia, and anemia.

Results:
The median overall survival was 6.9 months.

Support:
Some of the authors were employed by Hana Biosciences, makers of Marqibo.

Correspondence: Dr. M. A. Rodriguez; email: marodriguez@mdanderson.org

E-mail to a Friend Email Physician More Information